TickerLeague

Stock-Based Compensation for Zoetis (ZTS)

Stock-Based Compensation for Zoetis (ZTS): headline value $83.00M · YoY +12.2%. Annual and quarterly series, chart, and tables are below.

Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .

Latest period

$83.00M

YoY change

+12.2%

5Y CAGR

+7.1%

Peak year (2025)

$83.00M

Latest annual

$83.00M

Stock-Based Compensation history chart for Zoetis (ZTS) from 2009 to 2025

Stock-Based Compensation history table for Zoetis (ZTS) from 2009 to 2025

Fiscal yearPeriod endedReportedStock-Based CompensationYoY
2025$83.00M+12.2%
2024$74.00M+23.3%
2023$60.00M-3.2%
2022$62.00M+6.9%
2021$58.00M-1.7%
2020$59.00M-11.9%
2019$67.00M+26.4%
2018$53.00M+20.5%
2017$44.00M+18.9%
2016$37.00M-14.0%
2015$43.00M+34.4%
2014$32.00M-25.6%
2013$43.00M+53.6%
2012$28.00M+47.4%
2011$19.00M+18.8%
2010$16.00M+6.7%
2009$15.00M

Stock-Based Compensation values are taken from Zoetis's reported cash flow statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.

Analysis

In 2025, Zoetis (ZTS) stock-based compensation totalled $83.00M – grew 12.2% year-over-year.

Through 2020–2025 (5 years), Zoetis stock-based compensation delivered a +7.1% annualised rate; with the latest reading among the more recent periods of the dataset.

$83.00M stands as the all-time-high annual stock-based compensation, posted in 2025, against a low of $15.00M during 2009.

Among 8 Healthcare peers, Zoetis (ZTS) ranks 5th; the peer median for stock-based compensation is $313.00M.

Zoetis Stock-Based Compensation by Year

Zoetis Stock-Based Compensation 2025: $83.00M

Zoetis stock-based compensation in 2025 was $83.00M, grew 12.2% from 2024. This figure represents the highest annual value in the available history.

Zoetis Stock-Based Compensation 2024: $74.00M

Zoetis stock-based compensation in 2024 was $74.00M, grew 23.3% from 2023.

Zoetis Stock-Based Compensation 2023: $60.00M

Zoetis stock-based compensation in 2023 was $60.00M, edged down 3.2% below 2022.

Zoetis Stock-Based Compensation 2022: $62.00M

Zoetis stock-based compensation in 2022 was $62.00M, grew 6.9% from 2021.

Zoetis Stock-Based Compensation 2021: $58.00M

Zoetis stock-based compensation in 2021 was $58.00M.

See more financial history for Zoetis (ZTS).

Sector peers — Stock-Based Compensation

Companies in the same sector as Zoetis, ranked by their latest stock-based compensation.

CompanyStock-Based CompensationSector
Johnson & Johnson (JNJ)$1.35BHealthcare
UnitedHealth Group Incorporated (UNH)$971.00MHealthcare
AbbVie Inc. (ABBV)$955.00MHealthcare
Eli Lilly and Company (LLY)$626.00MHealthcare
AstraZeneca PLC (AZN)$0Healthcare
Merck & Co., Inc. (MRK)$0Healthcare
Amgen Inc. (AMGN)$0Healthcare
Novo Nordisk A/S (NVO)$0Healthcare

Frequently asked questions

What is Zoetis's stock-based compensation?

Latest reported stock-based compensation for Zoetis (ZTS) is $83.00M (period ending December 31, 2025).

How has Zoetis stock-based compensation changed year-over-year?

Zoetis (ZTS) stock-based compensation changed +12.2% year-over-year on the latest annual filing.

What is the long-term growth rate of Zoetis stock-based compensation?

Zoetis (ZTS) stock-based compensation compound annual growth rate is +7.1% over the most recent 5 years available.

When did Zoetis stock-based compensation hit its highest annual value?

Zoetis stock-based compensation reached its highest annual value of $83.00M in 2025.

What was Zoetis stock-based compensation in 2024?

Zoetis (ZTS) stock-based compensation in 2024 was $74.00M.

What was Zoetis stock-based compensation in 2025?

Zoetis (ZTS) stock-based compensation in 2025 was $83.00M.

Metrics overview

Pick a metric for charts, filings and peers — each row shows the latest TTM or most-recent-quarter value.